PG 9
Latest Information Update: 10 Dec 2001
Price :
$50 *
At a glance
- Originator Unknown
- Developer Nonindustrial source
- Class Analgesics
- Mechanism of Action Acetylcholine stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cognition disorders
Most Recent Events
- 10 Dec 2001 No-Development-Reported for Cognition disorders in Italy (Unknown route)
- 10 Dec 2001 No-Development-Reported for Cognition disorders in Japan (Unknown route)
- 19 Jan 2000 New profile